Serum profile of non-esterified fatty acids (NEFA) in patients with hyperlipoproteinemia under xantinol-nicotinate (XN) medication

Development and validation of a liquid chromatography–tandem mass spectrometry method for the determination of xanthinol in human plasma and its application in a bioequivalence study of xanthinol nicotinate tablets

“…As a result, Xanthinol Nicotinate has been used to treat peripheral vascular disorders, arteriosclerotic conditions [2,3] cerebrovascular insufficiency [4], dementia [5] and hyperlipoproteinemia [6], etc. The absorption of two xanthinol nicotinate formulations has been reported by measuring plasma levels of nicotinic acid [7].…”